Royal Bank Of Canada Krystal Biotech, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 2,777 shares of KRYS stock, worth $546,819. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,777

Previous 2,401 15.66%

Holding current value

$546,819

Previous $440,000 14.55%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$174.7 - $213.66 $65,687 - $80,336	376 Added 15.66%	2,777 $504,000
Q2 2024 Aug 14, 2024	BUY	$153.12 - $183.64 $210,846 - $252,872	1,377 Added 134.47%	2,401 $440,000
Q1 2024 Nov 05, 2024	SELL	$108.01 - $179.35 $148,729 - $246,964	-1,377 Reduced 57.35%	1,024 $182,000
Q1 2024 May 15, 2024	SELL	$108.01 - $179.35 $1.11 Million - $1.85 Million	-10,303 Reduced 90.96%	1,024 $182,000
Q4 2023 Feb 14, 2024	BUY	$96.0 - $128.29 $391,488 - $523,166	4,078 Added 56.26%	11,327 $1.41 Million
Q3 2023 Nov 14, 2023	BUY	$108.51 - $130.22 $616,011 - $739,258	5,677 Added 361.13%	7,249 $840,000
Q2 2023 Aug 14, 2023	BUY	$78.48 - $130.32 $21,660 - $35,968	276 Added 21.3%	1,572 $184,000
Q1 2023 May 15, 2023	SELL	$72.39 - $84.27 $127,551 - $148,483	-1,762 Reduced 57.62%	1,296 $103,000
Q4 2022 Feb 14, 2023	BUY	$63.14 - $79.9 $166,689 - $210,936	2,640 Added 631.58%	3,058 $242,000
Q3 2022 Nov 14, 2022	BUY	$64.85 - $82.4 $8,365 - $10,629	129 Added 44.64%	418 $29,000
Q2 2022 Aug 15, 2022	SELL	$48.93 - $73.47 $60,819 - $91,323	-1,243 Reduced 81.14%	289 $19,000
Q1 2022 May 16, 2022	SELL	$51.99 - $72.11 $105,851 - $146,815	-2,036 Reduced 57.06%	1,532 $102,000
Q4 2021 Feb 14, 2022	BUY	$39.81 - $88.24 $126,237 - $279,809	3,171 Added 798.74%	3,568 $249,000
Q3 2021 Nov 15, 2021	BUY	$52.01 - $71.77 $15,967 - $22,033	307 Added 341.11%	397 $21,000
Q2 2021 Aug 16, 2021	BUY	$62.14 - $81.82 $5,592 - $7,363	90 New	90 $6,000

Others Institutions Holding KRYS

# of Institutions

311

Shares Held

24.4M

Call Options Held

483K

Put Options Held

364K

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $5.05B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Krystal Biotech, Inc. Transaction History